Cargando…
The Role of Gut Microbiota and Its Produced Metabolites in Obesity, Dyslipidemia, Adipocyte Dysfunction, and Its Interventions
Obesity is becoming an increasing problem worldwide and is often, but not invariably, associated with dyslipidemia. The gut microbiota is increasingly linked to cardiovascular disease, nonalcoholic fatty liver disease, and type 2 diabetes mellitus. However, relatively little focus has been attribute...
Autores principales: | Zwartjes, Max S. Z., Gerdes, Victor E. A., Nieuwdorp, Max |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8398981/ https://www.ncbi.nlm.nih.gov/pubmed/34436472 http://dx.doi.org/10.3390/metabo11080531 |
Ejemplares similares
-
Gut Microbiome and Metabolites in Patients with NAFLD and after Bariatric Surgery: A Comprehensive Review
por: Hoozemans, Jacqueline, et al.
Publicado: (2021) -
The Gut Microbiome as a Target for the Treatment of Type 2 Diabetes
por: Aydin, Ömrüm, et al.
Publicado: (2018) -
The Role of the Gut Microbiota in the Gut–Brain Axis in Obesity: Mechanisms and Future Implications
por: van Son, Jamie, et al.
Publicado: (2021) -
Donor Fecal Microbiota Transplantation Alters Gut Microbiota and Metabolites in Obese Individuals With Steatohepatitis
por: Witjes, Julia J., et al.
Publicado: (2020) -
Gut Microbiota and Its Metabolites in Atherosclerosis Development
por: Pieczynska, Magdalena D., et al.
Publicado: (2020)